Gilder Gagnon Howe & CO LLC Procept Bio Robotics Corp Transaction History
Gilder Gagnon Howe & CO LLC
- $7.02 Billion
- Q1 2025
A detailed history of Gilder Gagnon Howe & CO LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 37,087 shares of PRCT stock, worth $2 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
37,087
Previous 37,822
1.94%
Holding current value
$2 Million
Previous $3.05 Million
29.06%
% of portfolio
0.03%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding PRCT
# of Institutions
303Shares Held
42.1MCall Options Held
286KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.13MShares$276 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$188 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.14MShares$115 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$76.2 Million0.05% of portfolio
-
State Street Corp Boston, MA1.19MShares$63.9 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.4B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...